Risk for cardiovascular disease increased for adult cancer survivors
Jul 05, 2022
Risk for CVD, heart failure, and stroke significantly increased after adjustment for cardiovascular risk factors
AHA advisory calls for regaining ‘lost ground’ in women’s heart health
May 10, 2022
Key indicators of women’s cardiovascular health are flagging, including blood pressure control, weight management and diabetes, AHA advisers say.
Flu shots lower risk of cardiac events by 34 percent: study
By
Alicia Lasek
May 04, 2022
A flu shot can offer significant protection to patients at high risk for adverse cardiovascular events, according to a new analysis.
No aspirin for heart disease prevention after 60, U.S. advisers say
By
Alicia Lasek
Apr 26, 2022
In major reversal, the U.S. Preventive Services Task Force announced the risks of using daily aspirin for heart disease protection outweigh the benefits for seniors. New evidence has also prompted the...
Cereal fiber tied to lower inflammation, CVD in older adults
Apr 08, 2022
Inflammation mediates approximately one-sixth of the association between cereal fiber intake and cardiovascular disease
Benefits of smoking cessation quantified in patients with ASCVD
Apr 08, 2022
About five event-free years gained through either quitting smoking or the use of three medications combined in persistent smokers
Coffee tied to better heart health, no added risk for Afib, studies find
Mar 25, 2022
Drinking two to three cups of coffee daily is linked to a lower risk of heart disease and atrial fibrillation, investigators say. The findings, across two studies, held true for people with and without...
Higher daily life movement cuts CVD risk in older women
Mar 09, 2022
Daily life movement includes things like performing housework or gardening
USPSTF updates guidance on statins for primary prevention of CVD
Feb 22, 2022
Statin use recommended for people aged 40 to 75 years with CV risk factor(s) and higher 10-year risk for a CV event
Clinical decision support may cut cardiovascular disease risk
Feb 10, 2022
Decreases seen for reversible risk in vulnerable patients with high baseline risk
